Mania Clinical Trials

5 recruiting

Mania Trials at a Glance

29 actively recruiting trials for mania are listed on ClinicalTrialsFinder across 6 cities in 33 countries. The largest study group is Phase 2 with 7 trials, with the heaviest enrollment activity in Miami, Richardson, and Chicago. Lead sponsors running mania studies include Bristol-Myers Squibb, Hayder Adnan Fawzi, and Institute of Tropical Medicine, Belgium.

Browse mania trials by phase

Treatments under study

About Mania Clinical Trials

Looking for clinical trials for Mania? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Mania trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Mania clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 29 trials

Recruiting

Diagnosis and Treatment of Leishmania Infections

LeishmaniasisSkin Diseases, ParasiticEuglenozoa Infections+1 more
National Institute of Allergy and Infectious Diseases (NIAID)289 enrolled1 locationNCT00344188
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine

Bipolar DisorderMania
Bristol-Myers Squibb424 enrolled103 locationsNCT07140913
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

Bipolar Disorder Type I With Mania or Mania With Mixed Features
Bristol-Myers Squibb274 enrolled74 locationsNCT06951711
Recruiting
Phase 3

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

Bipolar Disorder Type I With Mania
Bristol-Myers Squibb450 enrolled170 locationsNCT06929273
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

Bipolar-I Disorder With Mania or Mania With Mixed Features
Bristol-Myers Squibb274 enrolled63 locationsNCT06951698
Recruiting
Phase 3

Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.

Leishmaniasis, Cutaneous
Universidad de Antioquia96 enrolled1 locationNCT06822478
Recruiting

LEISH-PED: Study on Leishmaniasis in Children

Leishmania Infantum DiseaseLeishmaniasis, VisceralLeishmaniasis, Cutaneous+1 more
Meyer Children's Hospital IRCCS200 enrolled1 locationNCT07504757
Recruiting
Phase 2

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

Bipolar I DisorderMania
Neurocrine Biosciences150 enrolled6 locationsNCT07288320
Recruiting

A Novel Blood Test as a Biomarker in Mental Health

Depression - Major Depressive DisorderSubstance Use DisordersAlcohol Use Disorder+5 more
Fraser Health500 enrolled1 locationNCT06856161
Recruiting

Long-acting Injectable Antipsychotics for Mental Ill-Health in Pregnancy and Postpartum

PregnancySchizophreniaPsychosis+5 more
University of Liverpool125 enrolled6 locationsNCT05766007
Recruiting
Phase 2

Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults

Trichotillomania (Hair-Pulling Disorder)
Yale University20 enrolled1 locationNCT05207085
Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Streptococcus PneumoniaeMalariaMeningitis+55 more
Institut Pasteur du Cambodge10,000 enrolled1 locationNCT07358910
Recruiting

Introduction of Polymerase Chain Reaction (PCR) in Microbiology and Parasitology

Malaria, Pneumocystis, Leishmania
Fondazione IRCCS Policlinico San Matteo di Pavia200 enrolled1 locationNCT07269314
Recruiting
Not Applicable

Technology Assisted Treatment of Trichotillomania: Open Trial

Trichotillomania
HabitAware Inc.10 enrolled1 locationNCT07224126
Recruiting
Phase 2

Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis

Cutaneous Leishmaniasis
Hayder Adnan Fawzi40 enrolled1 locationNCT06797544
Recruiting
Phase 2

Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate

Cutaneous Leishmaniasis
Al-Mustafa University College80 enrolled1 locationNCT06798402
Recruiting
Phase 3

Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan

Old World Cutaneous Leishmaniasis
Medecins Sans Frontieres, Netherlands832 enrolled2 locationsNCT04268524
Recruiting

Deep Brain Stimulation-Induced Mania in Parkinson's Disease

Parkinson DiseaseMania
Albino Maia100 enrolled1 locationNCT05444907
Recruiting
Phase 2

Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral Miltefosine

Mucosal Leishmaniasis
Fundacion Nacional de Dermatologia30 enrolled1 locationNCT06550609
Recruiting
Phase 2

Intralesional Injection of Metronidazole for the Management of Cutaneous Leishmaniasis

Cutaneous Leishmaniasis
Hayder Adnan Fawzi40 enrolled1 locationNCT06798415